Altasciences today announced the continued expansion of their formulation, manufacturing, and analytical services facilities in Philadelphia, PA.
Sterile Packaging Industry Articles
Neurophth Announces the Completion of GMP Manufacturing Facility for Gene Therapy Products
Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, announced the opening of its state-of-the-art manufacturing facility at the Phase II Suzhou Biomedical Industrial Park (BioBAY) in Suzhou, China.
LifeScience Logistics Expands Into Raleigh-Durham
Responding to booming demand for FDA-regulated, temperature-controlled storage and distribution of pharmaceutical and medical devices, Dallas-based LifeScience Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today announced the company will be entering the Raleigh-Durham
AGT Unveils Cleanroom Technology, Energy Efficiency and Fast Build Times to Empower Growers
The Next Generation Greenhouse: AGT Unveils Cleanroom Technology, Energy Efficiency and Fast Build Times to Empower Growers
Sleek, modern structures full of patent-pending technologies such as Natural Earth Air System, oil bath fans and variable daylight control ushers in a new era for greenhouses
QuantumClean® & ChemTrace® Show How to Reduce Wafer Fab CoO at SEMICON Europa 2018
QuantumClean & ChemTrace will demonstrate how its ultra-high purity chamber tool part cleaning, proprietary coatings and microcontamination analytical testing can help reduce wafer fabrication Cost-of-Ownership (CoO). Solutions’ information is available during show hours at SEMICON Europa at the Messe München Exhibition Center in Munich, Germany from November 13 — 16, 2018 (booth A4510).
Cleanroom Farms of the Future
This “farm of the future”, built by systems integrator GrowStack working in conjunction with TCE Electrical Ltd., is the latest research initiative to be led by CHAP and Stockbridge Technology Centre (STC), a pioneer in experimental and applied horticulture research since the 1950s.
Bioresorbable Electronic Medicine
The scientists envision that such transient engineered technologies one day could complement or replace pharmaceutical treatments for a variety of medical conditions in humans. This type of technology, which the researchers refer to as a “bioresorbable electronic medicine,” provides therapy and treatment over a clinically relevant period of time and directly at the site where it’s needed, thereby reducing side effects or risks associated with conventional, permanent implants.
Lindström India launches India’s first cleanroom facility in Pune
Lindström India launched its second line of business, called Cleanroom services in India to ensure the highest quality hygiene, safety and reliability which is most critical to customers in the pharmaceutical, food and electronics industry. Lindström’s cleanroom service ensures hygienic production facilities by providing garments serviced in cleanroom laundries which prevent contaminations during process hereby ensuring complete safety of the products being manufactured.
Controlled Environmental Solutions Acquired by Cantel Medical Corp.
The Controlled Environmental Solutions business is made up of highly specialized testing and certification services, control procedures and tailored decontamination technology for the clean room to ensure optimal performance of the environment and end-user compliance to highly regulated industry standards.
Biomanufacturing Plant Is First Of It’s Kind In The United States
A next-generation biomanufacturing plant incorporates multiple innovative technologies into a single facility, and therefore is built in half the construction time with approximately one half of the operating cost of a traditional plant. The next-generation biomanufacturing plant require a smaller manufacturing footprint and offer greater environmental benefits, including reduced consumption of water and energy and lower levels of carbon emissions.
FDA Approves Anti-Cancer Drug For Advanced Paraganglioma
The U.S. Food and Drug Administration (FDA) has approved the first ever non-surgical treatment for the rare neuroendocrine cancers pheochromocytoma and paraganglioma. The approval was based on a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania and was granted to Progenics Pharmaceuticals for AZEDRA.
Platelet BioGenesis Moves to New Cambridge Cleanroom
Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of platelet-based therapeutics, announced it has moved into brand new lab space in Cambridge, MA. Located next to MIT, the newly renovated property puts Platelet BioGenesis in the heart of the most dynamic biotech cluster in the world.